RSS-Feed abonnieren

DOI: 10.1055/s-0042-1755270
Predictive value of serum initial brain natriuretic peptide and troponin on functional prognosis in noncardiogenic patients with anterior and posterior circulation cerebral infarction
Valor preditivo dos níveis séricos iniciais do peptídeo natriurético cerebral e da troponina no prognóstico funcional em pacientes não cardiogênicos com acidente vascular cerebral isquêmico de circulação anterior e posterior
Abstract
Background Brain natriuretic peptide (BNP) and troponin have a close relationship with cardiogenic cerebral embolism (CCE), but their relationship with noncardiogenic patients with anterior circulation ischemia (ACI) and posterior circulation ischemia (PCI) is not clear.
Objective To explore the predictive value of serum initial BNP and troponin on the functional prognosis of patients with noncardiogenic ACI and PCI.
Methods Consecutive patients with first-episode cerebral infarction within 12 hours of symptom onset were enrolled in the present 1-year prospective cohort study. Serum levels of BNP and troponin were collected within 12 hours of onset. Infarction location was classified as ACI and PCI by magnetic resonance imaging (MRI). According to the modified Rankin Scale (mRS) score at 90 days after onset, ACI and PCI cases were respectively divided into a good prognosis group (mRS score between 0 and 2) and a poor prognosis group (mRS score between 3 and 6). The general state of health and results of laboratory examinations and other auxiliary examinations of all patients were recorded. Single-factor analysis and multivariate logistic regression analysis were used to assess the relationship between serum levels of BNP, troponin, and functional outcome.
Results The multivariate logistic regression found that higher levels of initial BNP (odds ratio [OR] = 1.024; 95% confidence interval [CI]: 1.006–1.041; p = 0.007) and C-reactive protein (CRP) (OR = 1.184; 95%CI: 1.024–1.369; p = 0.022) were independent predictors of poor functional prognosis of noncardiogenic PCI at 90 days after onset after adjusting for age, gender, ethnicity, history of hypertension and of diabetes.
Conclusions The levels of initial BNP and CRP were related to poor functional outcomes in noncardiogenic PCI patients at 3 months, independent of troponin.
Resumo
Antecedentes O peptídeo natriurético cerebral (BNP, na sigla em inglês) e a troponina estão intimamente relacionados com a embolia cerebral cardiogênica (CCE, na sigla em inglês), mas a relação com pacientes não cardioembólicos com isquemia de circulação anterior (ICA) e isquemia de circulação posterior (ICP) não é clara.
Objetivo Investigar o valor preditivo dos níveis séricos iniciais do BNP e da troponina no prognóstico de pacientes com AVC isquêmico não cardiogênico.
Métodos Os níveis séricos de BNP e de troponina foram recolhidos de pacientes com primeiro episódio de acidente vascular cerebral (AVC) isquêmico dentro de 12 horas após o início dos sintomas, com localização classificada como ICA e ICP de acordo com exame de ressonância magnética (RM). De acordo com a pontuação modificada da escala de Rankin (mRS), aos 90 dias após o início dos sintomas, ICA e ICP foram divididas respectivamente em um grupo de bom prognóstico (mRS entre 0 e2) e em um grupo de mau prognóstico (mRS entre 3 e 6). Foram registrados exames laboratoriais e outros exames complementares de todos os pacientes. Foram utilizadas análise fatorial única e análise de regressão logística multivariada para investigar a relação entre os níveis séricos de BNP e de troponina e o resultado funcional.
Resultados A regressão logística multivariada evidenciou que os níveis mais altos de BNP inicial (odds ratio [OR] = 1,024, intervalo de confiança [IC] de 95%: 1,006–1,041; p = 0,007) e proteína C reativa (CRP, na sigla em inglês) (OR = 1,184; 95%CI: 1,024–1,369; p = 0,022) foram preditores independentes de mau prognóstico funcional da ICP não cardiogênica aos 90 dias após o início dos sintomas.
Conclusões Os níveis iniciais de BNP e CRP se associaram a maus resultados funcionais em pacientes com ICP não cardiogênica aos três meses, independentemente da troponina.
Keywords
Infarction, Anterior Cerebral Artery - Brain Infarction - Natriuretic Peptide, Brain - Troponin - C-Reactive Protein - Prognosis - EmbolismPalavras-chave
Infarto da Artéria Cerebral Anterior - Infarto Encefálico - Peptídeo Natriurético Encefálico - Troponina - Proteína C-Reativa - Prognóstico - EmboliaAuthors' Contributions
WTL: Participated in the study design and coordination; performed most of the experiments, analysis and interpretation of data; performed the statistical analysis and drafted the manuscript; WTD: Made the figures and drafted the manuscript; DSL: Participated in the statistical analysis and in the language polishing of the final version; JY: Carried out the experiments and sample collection; HYL: participated in the study design and coordination, conceptualization and methodology, material support for supervised study.
Publikationsverlauf
Eingereicht: 17. Juni 2021
Angenommen: 09. September 2021
Artikel online veröffentlicht:
19. Dezember 2022
© 2022. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Naghavi M, Abajobir AA, Abbafati C. et al; GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390 (10100): 1151-1210
- 2 Moran A, Gu D, Zhao D. et al. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes 2010; 3 (03) 243-252
- 3 Shen GX, Nan GX. Treatment progress of acute cerebral infarction. Jilin Med. 2013; 34 (15) 3022-3023 10.3969/j.issn.1004–0412.2013.15.138
- 4 Wang LD, Liu JM, Yang Y. The prevention and treatment of stroke still face huge challenges -brief report on stroke prevention and treatment in china,2018. Chinese Circulation Journal. 2019; 34 (02) 105-119 10.3969/j.issn.1000–3614.2019.02.001
- 5 Zürcher E, Richoz B, Faouzi M, Michel P. Differences in ischemic anterior and posterior circulation strokes: A clinico-radiological and outcome analysis. J Stroke Cerebrovasc Dis 2019; 28 (03) 710-718
- 6 Sparaco M, Ciolli L, Zini A. Posterior circulation ischaemic stroke-a review part I: anatomy, aetiology and clinical presentations. Neurol Sci 2019; 40 (10) 1995-2006
- 7 Inoa V, Aron AW, Staff I, Fortunato G, Sansing LH. Lower NIH stroke scale scores are required to accurately predict a good prognosis in posterior circulation stroke. Cerebrovasc Dis 2014; 37 (04) 251-255
- 8 Greving JP, Schonewille WJ, Wijman CAC, Michel P, Kappelle LJ, Algra A. BASICS Study Group. Predicting outcome after acute basilar artery occlusion based on admission characteristics. Neurology 2012; 78 (14) 1058-1063
- 9 Lee JH, Han SJ, Yun YH. et al. Posterior circulation ischemic stroke in Korean population. Eur J Neurol 2006; 13 (07) 742-748
- 10 Zeng Q, Tao W, Lei C, Dong W, Liu M. Etiology and risk factors of posterior circulation infarction compared with anterior circulation infarction. J Stroke Cerebrovasc Dis 2015; 24 (07) 1614-1620
- 11 Norris JW, Hachinski VC, Myers MG, Callow J, Wong T, Moore RW. Serum cardiac enzymes in stroke. Stroke 1979; 10 (05) 548-553
- 12 James P, Ellis CJ, Whitlock RML, McNeil AR, Henley J, Anderson NE. Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ 2000; 320 (7248): 1502-1504
- 13 Mäkikallio AM, Mäkikallio TH, Korpelainen JT. et al. Natriuretic peptides and mortality after stroke. Stroke 2005; 36 (05) 1016-1020
- 14 Gupta HV, Finlay CW, Jacob S, Raina SK, Lee RW, Hinduja A. Can admission bnp level predict outcome after intravenous thrombolysis in acute ischemic stroke?. Neurologist 2019; 24 (01) 6-9
- 15 Barber M, Morton JJ, Macfarlane PW, Barlow N, Roditi G, Stott DJ. Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke. Cerebrovasc Dis 2007; 23 (04) 260-266
- 16 Zhao Q, Zhang LJ, Li JW. Clinical Significance of Changes of Cardiac Troponin T and Other Biochemical Markers in Acute Ischemic Stroke Patients. Medical information. 2010; Nov, 23 (11) 3-3,5
- 17 Nigro N, Wildi K, Mueller C. et al. BNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events. PLoS One 2014; 9 (07) e102704
- 18 Wu CH. L B. The fourth national conference on cerebrovascular diseases. Chinese medical information bulletin,1996(06):4
- 19 Adams Jr HP, Bendixen BH, Kappelle LJ. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24 (01) 35-41
- 20 Sakamoto Y, Nito C, Nishiyama Y. et al. Accurate etiology diagnosis in patients with stroke and atrial fibrillation: A role for brain natriuretic peptide. J Neurol Sci 2019; 400: 153-157
- 21 Scheitz JF, Nolte CH, Laufs U, Endres M. Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke. Stroke 2015; 46 (04) 1132-1140
- 22 Merkler AE, Gialdini G, Murthy SB. et al. Association between troponin levels and embolic stroke of undetermined source. J Am Heart Assoc 2017; 6 (09) e005905
- 23 Zhao Q, Zhang LJ, Li JW. Clinical Significance of Changes of Cardiac Troponin T and Other Biochemical Markers in Acute Ischemic Stroke Patients. Medical information 2010; 23 (11) 3-3,5
- 24 Tomita H, Metoki N, Saitoh G. et al. Elevated plasma brain natriuretic peptide levels independent of heart disease in acute ischemic stroke: correlation with stroke severity. Hypertens Res 2008; 31 (09) 1695-1702
- 25 Shi H. Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem 2009; 16 (34) 4593-4600
- 26 Levin ER, Gardner DG, Samson WK. Mechanisms of disease-Natriuretic peptides. N Engl J Med 1998; Jul; 339: 321-328
- 27 Clerico A, Giannoni A, Vittorini S, Passino C. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. Am J Physiol Heart Circ Physiol 2011; 301 (01) H12-H20
- 28 Bieber M, Werner RA, Tanai E. et al. Stroke-induced chronic systolic dysfunction driven by sympathetic overactivity. Ann Neurol 2017; 82 (05) 729-743
- 29 Hachinski VC, Smith KE, Silver MD, Gibson CJ, Ciriello J. Acute myocardial and plasma catecholamine changes in experimental stroke. Stroke 1986; 17 (03) 387-390
- 30 Ay H, Koroshetz WJ, Benner T. et al. Neuroanatomic correlates of stroke-related myocardial injury. Neurology 2006; 66 (09) 1325-1329
- 31 Hasırcı B, Okay M, Ağırcan D, Koçer A. Elevated troponin level with negative outcome was found in ischemic stroke. Cardiovasc Psychiatry Neurol 2013; 2013 (953672): 953672
- 32 Abdi S, Oveis-Gharan S, Sinaei F, Ghorbani A. Elevated troponin T after acute ischemic stroke: Association with severity and location of infarction. Iran J Neurol 2015; 14 (01) 35-40
- 33 Fang QL, Shen T, Liu TJ. et al. The Relationship between Plasma Brain Natriuretic Peptide Level on Admission and Infarction Location in Patients with Acute Ischemic Stroke. Xiandai Shengwu Yixue Jinzhan 2014; 14 (18) 3465-3468 10.13241/j.cnki.pmb.2014.18.016
- 34 Menon B, Ramalingam K, Conjeevaram J, Munisusmitha K. Role of brain natriuretic peptide as a novel prognostic biomarker in acute ischemic stroke. Ann Indian Acad Neurol 2016; 19 (04) 462-466
- 35 Patel ML, Sachan R, Singh GP. et al. Assessment of subclinical atherosclerosis and endothelial dysfunction in chronic kidney disease by measurement of carotid intima media thickness and flow-mediated vasodilatation in North Indian population. J Family Med Prim Care 2019; 8 (04) 1447-1452
- 36 Cai Z, He W, Zhuang FJ, Chen Y. The role of high high-sensitivity C-reactive protein levels at admission on poor prognosis after acute ischemic stroke. Int J Neurosci 2019; 129 (05) 423-429
- 37 Tang CZ, Zhang YL, Wang WS, Li WG, Shi JP. Serum Levels of High-sensitivity C-Reactive Protein at Admission Are More Strongly Associated with Poststroke Depression in Acute Ischemic Stroke than Homocysteine Levels. Mol Neurobiol 2016; 53 (04) 2152-2160
- 38 Gommeren K, Desmas I, Garcia A. et al. Cardiovascular biomarkers in dogs with systemic inflammatory response syndrome. J Vet Emerg Crit Care (San Antonio) 2019; 29 (03) 256-263